Universitätsklinikum Ulm

Hospital


Location: Ulm, Germany (DE) DE

ISNI: -

ROR: https://ror.org/05emabm63

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients (2020) Karasu E, Demmelmaier J, Kellermann S, Holzmann K, Koehl J, Schmidt CQ, Kalbitz M, et al. Journal article Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triplenegative breast cancer, TNBC) (PM(Cb)) for patients (pts) with highrisk early breast cancer (BC) (2020) Schneeweiss A, Moebus V, Tesch H, Klare P, Denkert C, Kast K, Hanusch C, et al. Conference contribution GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status (2020) Link T, Blohmer JU, Just M, Untch M, Stoetzer O, Fasching P, Schneeweiss A, et al. Conference contribution Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332) (2020) Hauke J, Ernst C, Fasching P, Jackisch C, Seither F, Klare P, Rhiem KE, et al. Conference contribution Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2,-3, and-7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptore-positive, HER2-negative (HR+/HER2L) advanced breast cancer (ABC) (2020) Fasching P, Bardia A, Nusch A, Jerusalem G, Chan A, El Saghir N, Alba E, et al. Conference contribution Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B (gB) is inhibited by antibodies directed at antigenic domain 5 in the ectodomain of gB (2020) Reuter N, Kropff B, Schneiderbanger J, Alt M, Krawczyk A, Sinzger C, Winkler T, et al. Journal article A quantitative nuclear egress assay to investigate the nucleocytoplasmic capsid release of human cytomegalovirus (2020) Häge S, Horsch D, Stilp AC, Kicuntod J, Müller R, Hamilton ST, Egilmezer E, et al. Journal article SLC20A1 Is Involved in Urinary Tract and Urorectal Development (2020) Rieke JM, Zhang R, Braun D, Yilmaz Ö, Japp AS, Lopes FM, Pleschka M, et al. Journal article Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells (2020) Bosso M, Prelli Bozzo C, Hotter D, Volcic M, Stürzel CM, Rammelt A, Ni Y, et al. Journal article Summer is getting active - the self-introduction of GeSRU (2020) Koenig J, Mattigk A, Beck A, Wundrack FM, Bellut L, Fassbach M Journal article, Editorial